Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

15

Actual shortage: 12 (80%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 3 (20%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (7%)

Overdue reports

5 (42%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-CITALOPRAM 10MG TABLET Resolved 2018-11-23 2019-02-04 67518
NAT-DONEPEZIL 5MG TABLET Actual shortage 2018-07-13 2018-07-14 55625
NAT-DONEPEZIL 10MG TABLET Actual shortage 2018-07-13 2018-07-14 55630
NAT-ESCITALOPRAM 10MG TABLET Actual shortage 2019-02-15 2019-07-01 75793
NAT-ESCITALOPRAM 20MG TABLET Actual shortage 2019-02-15 2019-04-17 75799
NAT-LEVETIRACETAM 250MG TABLET Actual shortage 2019-02-15 2019-04-17 75810
NAT-LEVETIRACETAM 500MG TABLET Actual shortage 2018-10-19 2019-04-17 64878
NAT-LEVETIRACETAM 750MG TABLET Actual shortage 2019-04-17 2019-08-02 81921
NAT-QUETIAPINE 25MG TABLET Actual shortage 2018-10-31 2019-04-17 65944
NAT-QUETIAPINE 100MG TABLET Actual shortage 2019-04-17 2019-05-02 81900
NAT-QUETIAPINE 150MG TABLET Actual shortage 2019-04-23 2019-06-17 82236
NAT-QUETIAPINE 200MG TABLET Actual shortage 2019-04-17 2019-05-02 81903
NAT-QUETIAPINE 300MG TABLET Actual shortage 2019-04-17 2019-05-02 81906
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67512
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67515
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports